CryoLife, Inc. (NYSE:CRY)
The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
recycle -30
Recs
Because I said so.
Recs
My long term view is postive given the new product development and increasing revenues. It's puzzling how this managemet team seems unable to avoid "shooting itself in the foot" every quarter with some decision that drves the stock price down.
Recs
This pick is pure speculation.
Recs
I like the management,and Ilike what this company is doing
Recs
Goog growth and earnings.
Recs
Good potential with Cryolife.
Recs
I was turned on to this by another fool. When I went to look I saw a solid stock that is recession proof but what really made me look hard is their R&D projects. If they can get thier BioGlue to work for herniated discs this could be off and running. Also they have goverment funding to research BioFoam to help stop wounded soldiers in the field. Speculative on the upside and solid on the earnings side so as to not lose if the new projects don't come to fruition. Worth the risk and am buying some in my personal account.
Recs
CryoLife's primary product is involved in the treatment of heart disease, the number one killer of men and women. In fact, one of every four deaths is due to the disease, so I like their prospects in that regard. They exhibit solid growth in revenue and net income while trading a very modest P/E ratio of about 6.5
Recs
This company will rebound
Recs
A no brainer. Enormous value, in a sector on the rise. With McDonalds's (MCD) climbing, cardiovascular tissue will be in sky-scraping demand! Look out, Cryolife's on the move and packing heat, BioFoam heat that is.
Recs
Great Fundamentals with services that will be needed much more in the future. Currently undervalued. The management seems to be focus on sales and growth. Mid-Longterm Investment. IMHO
Recs
I can't find any reason why this stock is Down??? It appears to be well managed. ( CGQ Ratios are 93% Better than S&P 600 & 93% Better than other Health Care Co's. It has a Fantastic Line of Products ( in addition to "parts" like tissue & heart valves-- it also has BioGlue, ProPatch & CardioWrap.) --which it sells internationally. It has GREAT Profits & ROE --- Best of all...it has almost NO Debt !!!
Recs
big discounted stock
Recs
First of all, the bioglue and tissue preservation services will only become more valuable in the future. The demand for such things will only increase with the population, and although the share price has fallen, the true value of the company will eventually be recognized. This, however, is only my first impression of the company and is merely my own personal opinion. Take from it what you will.
Cryolife also seems focused on putting their products in more doctors and specialists hands. The most recent presentation at the Sidoti's Forum shows their intent to more aggressively market their goods. The 51 person sales team has been aimed directly at cardiac and vascular surgeons. Management also seem s focused on protecting/expanding their core markets.
I believe we will see a turnaround by next quarter with continuous growth for a long while thereafter. Let's just hope there isn't another lawsuit filed against them over bad tissue again.
Outperform 1Y.
Recs
Recs
Great industry, great fundamentals.
Recs
Strong fundamentals.
Recs
I would love to see this company explode and make it to the top. With the way america's health is according to the news we'll all be needing this company to prosper. I'm hoping they have a good board of directors to lead them into the future.
Recs
Good new products (high priced and much-required products)
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 42 : 1 2 3 Next »